The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing nanoparticle immunomodulatory drugs.

Total Raised

$133 M

Rounds

7

Links

Verticals

Biopharma
Biotechnology
Pharmaceutical

Investment History

  1. Series E

    Sep 2015

    $38M

  2. Equity

    Oct 2014

    $20M

  3. Grant

    Jun 2014

    $1M

  4. Equity

    Oct 2011

    $47M

  5. Grant

    Aug 2010

    $3M

Team

Omid C. Farokhzad

Founder, Board of Directors and Vice Chairman on the Board

Lloyd Johnston

Chief Operating Officer and Senior Vice President R&D

David Abraham

General Counsel and Corporate Secretary

Peter G. Traber

Chief Medical Officer